tilmicosin and Heart-Septal-Defects--Ventricular

tilmicosin has been researched along with Heart-Septal-Defects--Ventricular* in 1 studies

Other Studies

1 other study(ies) available for tilmicosin and Heart-Septal-Defects--Ventricular

Article	Year
Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects. The Canadian veterinary journal = La revue veterinaire canadienne, 2009, Volume: 50, Issue:1 A 15-day-old, 6.08 kg, lamb was injected subcutaneously with tilmicosin 15 mg/kg body weight. Approximately 15 min later, the lamb died. During necropsy, the heart was found to have multiple ventricular septal defects. Death was attributed to sudden heart failure due to the cardiac effects of tilmicosin in a heart having congenital defects. Topics: Animals; Animals, Newborn; Death, Sudden, Cardiac; Fatal Outcome; Heart Septal Defects, Ventricular; Sheep; Sheep Diseases; Tylosin	2009

Article

Year

Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects.

The Canadian veterinary journal = La revue veterinaire canadienne, 2009, Volume: 50, Issue:1

A 15-day-old, 6.08 kg, lamb was injected subcutaneously with tilmicosin 15 mg/kg body weight. Approximately 15 min later, the lamb died. During necropsy, the heart was found to have multiple ventricular septal defects. Death was attributed to sudden heart failure due to the cardiac effects of tilmicosin in a heart having congenital defects.

Topics: Animals; Animals, Newborn; Death, Sudden, Cardiac; Fatal Outcome; Heart Septal Defects, Ventricular; Sheep; Sheep Diseases; Tylosin

2009